| 000 | 01534 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513192001.0 | ||
| 264 | 0 | _c19991112 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0804-4643 | ||
| 024 | 7 |
_a10.1530/eje.0.1410313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRigamonti, A E | |
| 245 | 0 | 0 |
_aSix-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin. _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cSep 1999 |
||
| 300 |
_a313-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEating _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Hormone _xmetabolism |
| 650 | 0 | 4 |
_aGrowth Hormone-Releasing Hormone _xpharmacology |
| 650 | 0 | 4 |
_aGrowth Substances _xadministration & dosage |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aSomatostatin _xadministration & dosage |
| 700 | 1 | _aCella, S G | |
| 700 | 1 | _aMarazzi, N | |
| 700 | 1 | _aMüller, E E | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 141 _gno. 3 _gp. 313-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/eje.0.1410313 _zAvailable from publisher's website |
| 999 |
_c10431588 _d10431588 |
||